[Form 4] MILESTONE SCIENTIFIC INC. Insider Trading Activity

Rhea-AI Filing Summary

Milestone Scientific (MLSS) disclosed insider stock sales on a Form 4. The reporting person sold common stock in three transactions: 10,158 shares on 10/10/2025 at $0.5501, 10,000 shares on 10/13/2025 at $0.55, and 30,000 shares on 10/14/2025 at $0.5395. Following these transactions, the reporting person beneficially owned 9,155,226 shares, held directly.

Insights

Equity market structure analyst

Routine insider sales with large remaining direct stake.

The filing lists three open-market sales of Milestone Scientific common stock across 10/10/2025–10/14/2025 at per‑share prices between $0.5395 and $0.5501. Transaction code “S” indicates sales.

Post-trade beneficial ownership is disclosed at 9,155,226 shares, labeled as direct. The document does not specify proceeds use or any corporate action; the effect depends on holder decisions and market liquidity.

Subsequent filings may provide additional context on trading plans or further changes in ownership if they occur.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BP4 S.r.l.

(Last) (First) (Middle)

CORSO VENEZIA 44

(Street)

MILAN, L6 20121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MILESTONE SCIENTIFIC INC. [ MLSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, Par Value $0.001	10/10/2025		S		10,158	D	$0.5501	9,185,226	D
Common Stock, Par Value $0.001	10/13/2025		S		10,000	D	$0.55	9,175,226	D
Common Stock, Par Value $0.001	10/14/2025		S		30,000	D	$0.5395	9,155,226	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/S/ Dr. Pedro Palau, Liquidator	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MLSS disclose in this Form 4?

Three open-market sales of common stock by a reporting person, with post-transaction beneficial ownership of 9,155,226 shares held directly.

How many MLSS shares were sold and on what dates?

Sales of 10,158 shares on 10/10/2025, 10,000 on 10/13/2025, and 30,000 on 10/14/2025.

At what prices were the MLSS shares sold?

Reported sale prices were $0.5501, $0.55, and $0.5395 per share.

How many MLSS shares does the insider now own?

The filing shows beneficial ownership of 9,155,226 shares following the reported transactions.

What is the ownership form after these transactions?

The filing labels the ownership form as Direct (D).

What is the issuer’s name and ticker?

The issuer is Milestone Scientific Inc. (MLSS).